Clinical Trial Update: A Clinical Trial to Assess the Efficacy and Safety of an Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children Aged 6-35 Months [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of a Vero cell-derived inactivated EV71 vaccine in Chinese children aged 6-35 months; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Foot and Mouth Disease
• Herpangina

Drugs mentioned

• EV71 vaccine (inactivated, Vero cell-derived) (enterovirus 71 vaccine, inactivated, Vero cell-derived)

Snippet

Sponsor: Jiangsu Province Centers for Disease Control and Prevention | Conditions: Hand, Foot and Mouth Disease, Herpangina | Phase 3 | Status: COMPLETED